{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:27:21Z","timestamp":1773235641158,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":47,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005162.pub3","type":"reference-entry","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:04:30Z","timestamp":1346781870000},"source":"Crossref","is-referenced-by-count":46,"title":["Terlipressin for hepatorenal syndrome"],"prefix":"10.1002","author":[{"given":"Lise Lotte","family":"Gluud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"10.1002\/14651858.CD005162.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"165A","DOI":"10.1016\/0270-9139(95)94386-2","article-title":"Terlipressin in the treatment of hepatorenal syndrome (HRS): a double blind cross-over study","volume":"22","author":"Hadengue","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0168-8278(07)61680-8","article-title":"Randomized, comparative study of terlipressin and albumin vs albumin alone in patients with cirrhosis and hepatorenal syndrome","volume":"46","author":"Martin-Llahi","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD005162.pub3-BIB6|cit6","first-page":"694A","article-title":"A prospective, randomized, double blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS)","volume":"44","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB8|cit8","first-page":"1071A","article-title":"Effect of terlipressin on mean arterial pressure (MAP) and its relation to serum creatinine concentration in type ! hepatorenal syndrome (HRS): analysis of data from the pivotal phase 3 trial","volume":"48","author":"Sanyal","year":"2008","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB9|cit9","first-page":"565A","article-title":"Prognostic factors for hepatorenal syndrome (HRS) in patients with type 1 HRS enrolled in a randomized double-blind, placebo-controlled trial","volume":"46","author":"Sanyal","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB11|cit11","first-page":"123","article-title":"[Efficacy of terlipressin in treatment of liver cirrhosis with hepatorenal syndrome]","volume":"7","author":"Yang","year":"2001","journal-title":"Journal of Internal Intensive Medicine"},{"key":"10.1002\/14651858.CD005162.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0168-8278(06)80204-7","article-title":"Noradrenaline vs terlipressin in hepatorenal syndrome: a prospective, randomized study","volume":"44","author":"Alessandria","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB14|cit14","first-page":"378A","article-title":"Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical study","volume":"48","author":"Angeli","year":"2008","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1590-8658(12)60030-9","article-title":"Terlipressin and albumin vs midodrine plus octreotide in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled trial by the Italian association for the study of the liver","volume":"44","author":"Cavallin","year":"2012","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD005162.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(03)80588-3","article-title":"Captopril in low dose associated with octreotide in hepatorenal syndrome: A randomized study","volume":"38","author":"Chelarescu","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB19|cit19","first-page":"449A","article-title":"Noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome: a randomzied controlled trial","volume":"44","author":"Sharma","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD005162.pub3-BIB20|cit20","first-page":"1946","article-title":"Efficacy of terlipressin and albumin in the treatment of hepatorenal syndrome","volume":"12","author":"Silawat","year":"2011","journal-title":"World Applied Sciences Journal"},{"key":"10.1002\/14651858.CD005162.pub3-BIB21|cit21","unstructured":"Terlipressin + albumin versus midodrine + octreotide in the treatment of hepatorenal syndrome. Ongoing study"},{"key":"10.1002\/14651858.CD005162.pub3-BIB22|cit22","unstructured":"A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin. Ongoing study"},{"key":"10.1002\/14651858.CD005162.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8278(00)80423-7","article-title":"Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem","volume":"32","author":"Arroyo","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1665-2681(19)32154-4","article-title":"Hepatorenal syndrome","volume":"2","author":"Cardenas","year":"2003","journal-title":"Annals of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD005162.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11255-010-9725-8","article-title":"Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis","volume":"43","author":"Dobre","year":"2011","journal-title":"International Urology and Nephrology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"International Journal of Artificial Organs"},{"key":"10.1002\/14651858.CD005162.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(82)91689-0","article-title":"Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices","volume":"2","author":"Freeman","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005162.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005162.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD005162.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/sim.4088","article-title":"Sequential methods for random-effects meta-analysis","volume":"30","author":"Higgins","year":"2011","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005162.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-008-0118-7","article-title":"Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome","volume":"25","author":"Krag","year":"2008","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD005162.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2004.02112.x","article-title":"Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?","volume":"20","author":"Moller","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD005162.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1592\/phco.24.11.1050.36144","article-title":"The role of vasopressin in vasodilatory septic shock","volume":"24","author":"Obritsch","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD005162.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000044879","article-title":"Circadian rhythm of arginine vasopressin in hepatorenal syndrome","volume":"78","author":"Pasqualetti","year":"1998","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD005162.pub3-BIB37|cit37","unstructured":"The Nordic Cochrane Center Review Manager (RevMan), version 5.0 2008"},{"key":"10.1002\/14651858.CD005162.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB40|cit40","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1002\/14651858.CD005162.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.20044","article-title":"Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy","volume":"39","author":"Shawcross","year":"2004","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB42|cit42","unstructured":"Stata Corp STATA 2007"},{"key":"10.1002\/14651858.CD005162.pub3-BIB43|cit43","unstructured":"The Copenhagen Trial Unit. Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. www.ctu.dk\/tsa Trial Sequential Analysis 2008"},{"key":"10.1002\/14651858.CD005162.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD005162.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005162.pub3-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005162.pub2","article-title":"Terlipressin for hepatorenal syndrome","author":"Gluud","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005162.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005162.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005162.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:45:43Z","timestamp":1628531143000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005162.pub3"}},"subtitle":[],"editor":[{"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005162.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958467.793462968","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958467.793464593","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,9,12]]}}}